JPRN-jRCTs051210170招募中未知
Bolus Administration of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy after Emergency Percutaneous Coronary Intervention. - Bolus-pCINC Study
Watanabe Makoto0 个研究点目标入组 260 人开始时间: 2022年2月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1 20 years old and over
- •2 Patients heading directly to the cardiac catheterization laboratory from the emergency outpatient department or patients with in-hospital onset
- •3 Patients with suspected acute myocardial infarction based on changes in electrocardiogram, elevation of myocardial enzyme, or echocardiography
- •4 Patients who consented to patient or legal acceptable representative in the study
排除标准
- •1 Patients with shock or cardiopulmonary arrest upon arrival at the emergency department
- •2 Patients with impaired consciousness, orthopnoea, or needing tracheal intubation and non-invasive positive pressure ventilation (NIPPV) upon arrival at emergency department
- •3 Patients who received oral or intravenous sodium bicarbonate before CAG was performed
- •4 Patients who are allergic to contrast agents at the time of registration
- •5 Patients who undergoing dialysis
- •6 Patients who uncontrolled hyperthyroidism or hypothyroidism
- •7 Patients who received contrast media within 7 days of CAG or PCI
- •8 Patients who did not undergo PCI as the result of CAG
- •9 Patients who did not diagnosed with acute myocardial infarction
研究者
相似试验
未知
2 期
Sodium Bicarbonate Infusion at Low Concentration to Reduce Kidney Insufficiency by Angiographic Non-iodinated Contrast MediaContrast-Induced NephropathyJPRN-C000000419Department of Cardiovascular Medicine, Kyoto University Hospital500
已完成
3 期
Effect of Oral Sodium Bicarbonate Supplementation on urine TGF-beta in normal serum bicarbonate CKD, A randomized control trial.on-diabetic chronic kidney disease with subclinical metabolic acidosisBicarbonate, urine TGF-beta, urine ammonium, chronic kidney diseaseTCTR20240817007Department of Medicine, Phramongkutklao Hospital and College of Medicine64
进行中（未招募）
不适用
Sodium Bicarbonate for the prevention of Contrast Induced Nephropathy in patients undergoing CTPA - The Nephros StudyThe prevention of Contrast Induced Nephropathy is under investigation.Contrast induced nephropathy (CIN) can occur after injecting radiographic iso osmolair contrast media. Patients with a renal impairment or a decreased renal function and aspecially in combination with diabetis mellitus are at risk for developing CIN.MedDRA version: 12.0Level: LLTClassification code 10037790Term: Radiocontrast nephropathyEUCTR2009-013547-11-NLeids Universitair Medisch Centrum
已完成
4 期
Sodium Bicarbonate for kidney protection in patients undergoing liver transplantatioiver transplantationLiver transplantationAnaesthesiology - AnaestheticsSurgery - Other surgeryRenal and Urogenital - Other renal and urogenital disordersAcute Kidney InjuryACTRN12611001290987Austin Hospital60
进行中（未招募）
不适用
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal InsufficiencyDiabetes mellitus with renal insufficiencyMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2007-007546-36-CZInstitute for Clinical and Experimental Medicine